<?xml version="1.0" encoding="UTF-8" ?>

<Genomics_ConceptTask>
<TEXT><![CDATA[Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent 
Protection against SARS-CoV-2.

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2) threatens global public health. 
The development of a vaccine is urgently needed for the prevention and control 
of COVID-19. Here, we report the pilot-scale production of an inactivated 
SARS-CoV-2 vaccine candidate (BBIBP-CorV) that induces high levels of 
neutralizing antibodies titers in mice, rats, guinea pigs, rabbits, and nonhuman 
primates (cynomolgus monkeys and rhesus macaques) to provide protection against 
SARS-CoV-2. Two-dose immunizations using 2 μg/dose of BBIBP-CorV provided highly 
efficient protection against SARS-CoV-2 intratracheal challenge in rhesus 
macaques, without detectable antibody-dependent enhancement of infection. In 
addition, BBIBP-CorV exhibits efficient productivity and good genetic stability 
for vaccine manufacture. These results support the further evaluation of 
BBIBP-CorV in a clinical trial.62q  kv ]]></TEXT>
<TAGS>
<CONTEXT id="C0" spans="798~814" text="rhesus  macaques" experiment_type="organism" species="other" />
<CONTEXT id="C1" spans="520~524" text="mice" experiment_type="organism" species="mouse" />
<CONTEXT id="C2" spans="526~530" text="rats" experiment_type="organism" species="rat" />
<CONTEXT id="C3" spans="532~543" text="guinea pigs" experiment_type="organism" species="other" />
<CONTEXT id="C4" spans="545~552" text="rabbits" experiment_type="organism" species="other" />
<CONTEXT id="C5" spans="558~617" text="nonhuman  primates (cynomolgus monkeys and rhesus macaques)" experiment_type="organism" species="other" />
</TAGS>
</Genomics_ConceptTask>